Search clinical trials for: Primary Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) induced AML.
Total 475511 results
-
Assiut UniversitySouth Egypt Cancer InstituteCompletedAcute Myeloid LeukemiaEgypt
-
University Health Network, TorontoCompleted
-
Brown UniversityMemorial Hospital of Rhode Island; Roger Williams Medical CenterTerminated
-
BioSight Ltd.Active, not recruitingRefractory Acute Myeloid Leukemia | MDS | AML, Adult | Relapse/RecurrenceUnited States
-
Byondis B.V.RecruitingRelapsed / Refractory AML | Relapsed / Refractory MDSSpain, Netherlands, Belgium
-
Rubius TherapeuticsTerminated
-
Abramson Cancer Center at Penn MedicineBristol-Myers SquibbRecruiting
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalTerminatedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic SyndromeUnited States
-
Centre Hospitalier Universitaire de NiceRecruiting
-
Princess Maxima Center for Pediatric OncologyDaiichi SankyoRecruitingAcute Myeloid Leukemia in ChildrenNetherlands
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingMyelodysplastic Syndromes | Secondary Acute Myeloid LeukemiaUnited States
-
Newave Pharmaceutical IncActive, not recruitingRefractory Acute Lymphoblastic Leukemia | Relapse | CMML | Relapsed Adult AML | AML/MDS | Relapse LeukemiaUnited States, Spain
-
Nantes University HospitalInstitut National de la Santé Et de la Recherche Médicale, FranceNot yet recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaFrance
-
Gwynn Long, M.D.ADC Therapeutics S.A.TerminatedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS) | Myeloproliferative Neoplasm (MDS/MPN)United States
-
Novartis PharmaceuticalsCompletedAcute Myelogenous Leukemia | Refractory LeukemiaBelgium, Korea, Republic of, Turkey, Germany, Australia, France, Switzerland, United Kingdom, Spain, Italy, Peru, United States
-
Hackensack Meridian HealthTerminatedMyeloproliferative Disorders | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia | Myeloid MalignanciesUnited States
-
The First Affiliated Hospital of Soochow UniversityRecruitingAcute Myeloid LeukemiaChina
-
Assistance Publique - Hôpitaux de ParisCompletedMyelodysplastic Syndrome (MDS) | Acute Myelogenous Leukaemia (AML)France
-
Turkish Leukemia Study GroupCompleted
-
ASLAN PharmaceuticalsCompletedAcute Myeloid LeukemiaUnited States, Australia, Singapore
-
Synta Pharmaceuticals Corp.CompletedMyeloproliferative Disorders | AML | MDS | CMLUnited States
-
Novartis PharmaceuticalsCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
Heinrich-Heine University, DuesseldorfCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeGermany
-
Maximilian Stahl, MDSyndax PharmaceuticalsNot yet recruitingAcute Myeloid Leukemia | Leukemia | AML | AML, Adult | AML With Gene MutationsUnited States
-
Groupe Francophone des MyelodysplasiesCelgene CorporationTerminatedMyelodysplastic Syndromes | Leukemia, Myelocytic, AcuteFrance
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalCompletedAcute Myelogenous Leukemia | MyelodysplasiaUnited States
-
Jasper Therapeutics, Inc.RecruitingMYELODYSPLASTIC SYNDROME; MDS | ACUTE MYELOID LEUKEMIA; AMLUnited States
-
Zeinab Albadry Mohammed ZahranCompletedTherapy Related Myelodysplastic Syndrome and Therapy Related Acute Myeloid LeukemiaEgypt
-
Ioannis MantzarisAbbVieRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
New York Medical CollegeCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Sherif FaragWithdrawn
-
Assiut UniversityNot yet recruiting
-
Washington University School of MedicineNotable LabsRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical CenterTerminatedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic SyndromeUnited States
-
Van Andel Research InstituteCompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia | AML | MDS | CMMLUnited States
-
Daiichi Sankyo, Inc.CompletedAcute Myeloid Leukemia | Leukemia | AML | Myelodysplastic Syndrome | MDSUnited States, Georgia
-
Novartis PharmaceuticalsCompletedAML and High Risk MDSGermany, Italy, France, Netherlands, United States, Australia, Japan
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Spain, Singapore, Australia, Germany, Italy, Finland, United States
-
Weill Medical College of Cornell UniversityPfizer; Jazz PharmaceuticalsTerminatedAcute Myeloid LeukemiaUnited States
-
Clinical Hub for Interventional Research (CHOIR)The University of New South Wales; Australian National UniversityRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaAustralia
-
M.D. Anderson Cancer CenterTerminatedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
University of FloridaThe Leukemia and Lymphoma SocietyTerminatedMyelodysplastic Syndromes | Leukemia, Myelogenous, AcuteUnited States
-
ViaCellCompletedAcute Myeloid Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Acute Lymphocytic Leukemia | Chronic Myelogenous LeukemiaUnited States
-
New York Medical CollegeCompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
Zhejiang UniversityHangzhou Qihanjiyin Biotech Co.,Ltd.Recruiting
-
GlaxoSmithKlineActive, not recruitingLeukemia, Myeloid, AcuteGermany, Italy, Spain, Netherlands, Canada
-
Novartis PharmaceuticalsWithdrawnAcute Myeloid Leukemia (AML)
-
Assiut UniversityUnknownDetection of PCM1-JAK2 Fusion Gene by FISH in the Two Types of t-MDS/AML and Relationship Between PCM1-JAK2 Fusion Gene and Cumulative Dose, Dose Intensity
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States